GangaGen raises $1.8M for bacteria treatments
GangaGen is a biotech company that’s working on bacteriophages, which are viruses that infect and destroy bacteria. The company raised $1.8 million to develop treatments for antibiotic-resistant bacterial infections like pneumonia and MRSA, a skin infection that plagues hospitals.
This is the San Francisco, Calif. company’s first funding round. ATEL Ventures made the investment.
Next Story: Industrial Origami funded with $17M for metal-folding magic
Previous Story: Location comes to the web browser with Mozilla’s Geode
About the Author, Chris Morrison
Chris Morrison writes about cleantech and environmental issues for VentureBeat, with occasional forays into gaming and semantic technology. He got his start writing about tech for Business 2.0 magazine, but quickly realized new media was the ticket when that institution closed its doors in 2007. Chris has also covered public equities and regulatory issues. He originally hails from southern Virginia, graduated from Evergreen State College in Washington, and now lives in San Francisco.